Large‑Cap Weakness Hits Tech and Retail: Zscaler Leads a Week of Sharp Declines
A group of heavyweight stocks posted the steepest losses last week, with cybersecurity firm Zscaler tumbling over 20%. The sell‑off spanned sectors from medical devices to auto parts, prompting investors to reassess exposure amid mixed earnings and downgrades.
During the week ending May 29, ten large‑cap equities registered the largest percentage drops on major U.S. exchanges. The most dramatic move came from Zscaler Inc., whose shares slumped more than one‑fifth after the company released its third‑quarter results and projected fourth‑quarter revenue at the low end of analysts’ expectations. The guidance shortfall sparked a wave of sentiment deterioration, pushing the stock well below its 50‑day moving average and leaving it near the lower bound of its 52‑week range.
Zscaler’s decline is particularly striking given its recent recovery from a steep multi‑year downturn; the stock now trades at roughly 58% below its all‑time high. While the company posted solid top‑line growth, margin compression and heightened competition in the cloud security market raised concerns about sustainable profitability. Wall Wall estimates still see upside potential near $277 per share, but the consensus price target implies a nearly 100% upside from current levels, highlighting the disconnect between short‑term performance and longer‑term expectations.
Boston Scientific also experienced a sharp fall of almost 17% after several research houses trimmed their earnings forecasts. The medical‑device maker cited weaker demand for its cardiovascular portfolio and rising input costs, factors that could pressure margins if the trend persists. For investors with exposure to healthcare, the move underscores the sector’s sensitivity to both macroeconomic headwinds and product‑specific setbacks.
Retail supplier AutoZone posted a 14% slide following its quarterly earnings release. Although revenue beat expectations, analysts lowered price targets after noting slower same‑store sales growth and inventory buildup concerns. The auto‑parts retailer operates in a cyclical environment where consumer spending on vehicle maintenance can be volatile; the recent pullback suggests that investors may be pricing in a potential slowdown in discretionary automotive spend.
Other notable decliners included Cerebras Systems, a high‑performance computing firm, which fell nearly 17% amid broader tech sector weakness, and PDD Holdings, the Chinese e‑commerce platform, down about 9% after analysts reduced price forecasts citing regulatory uncertainty and slowing growth in its core markets. Energy‑related names such as Venture Global and Imperial Oil also slipped as oil prices retreated following diplomatic developments concerning U.S.–Iran negotiations.
From a portfolio perspective, these moves highlight the importance of monitoring earnings guidance and analyst sentiment, especially for high‑growth stocks that trade at elevated valuations. Investors holding Zscaler should evaluate whether the current price reflects temporary execution challenges or deeper competitive pressures. The stock’s technical profile—trading below both its 50‑day (97% of SMA) and 200‑day (63% of SMA) moving averages—signals bearish momentum, but a rebound in cloud security spending could provide a catalyst for recovery.
Overall, the week’s performance serves as a reminder that large‑cap stocks are not immune to sharp corrections, particularly when earnings miss or guidance falls short. Market participants should weigh the balance between valuation, growth prospects, and sector-specific risks before making allocation decisions.
ZS Stock Data
Key Takeaways
- Zscaler led the week with a >20% drop after issuing fourth‑quarter revenue guidance below consensus estimates.
- Boston Scientific and AutoZone also suffered steep declines following analyst forecast cuts and mixed earnings signals.
- Several stocks are trading well under their 50‑day and 200‑day moving averages, indicating bearish technical momentum.
- Consensus price targets suggest significant upside potential for some lagging names, but investors must assess whether fundamentals justify the gap.
- The sell‑off spans tech, healthcare, retail and energy, underscoring the need for diversified risk management in large‑cap portfolios.